HALOZYME THERAPEUTICS INC - NOTE 1.000% 8/1

Historical Holders from Q3 2023 to Q3 2025

Type / Class
Debt / NOTE 1.000% 8/1
All holders as of 30 Sep 2025
Q3 2025
Total 13F principal, excl. options
620,325,460
Holdings value
$871,115,291
% of all portfolios
0.002%
Number of holders
62
Number of buys
23
Number of sells
-45
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of HALOZYME THERAPEUTICS INC - NOTE 1.000% 8/1

Period Principal Value Change Price Investors
2025 Q3 620,325,460 $871,115,291 +$88,146,938 $1.41 62
2025 Q2 628,830,300 $718,645,608 -$27,561,128 $1.14 74
2025 Q1 647,508,446 $828,761,473 +$4,645,168 $1.28 77
2024 Q4 672,476,260 $730,001,496 -$62,779,579 $1.08 77
2024 Q3 680,559,400 $810,707,471 +$105,250,543 $1.19 75
2024 Q2 23,972,237,400 $717,063,397 -$3,930,381 $1.11 72
2024 Q1 623,774,400 $607,993,350 -$28,940,823 $0.974 70
2023 Q4 658,912,150 $616,721,993 -$3,988,874 $0.9309 72
2023 Q3 660,082,850 $622,263,753 +$620,529,779 $0.9371 64